409 related articles for article (PubMed ID: 18191077)
41. Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats.
Ortinau LC; Nickelson KJ; Stromsdorfer KL; Naik CY; Pickering RT; Haynes RA; Fritsche KL; Perfield JW
Obesity (Silver Spring); 2013 Feb; 21(2):344-52. PubMed ID: 23404766
[TBL] [Abstract][Full Text] [Related]
42. Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus.
Sakano K; Takahashi M; Mutoh M; Niho N; Komiya M; Sato H; Tanaka T; Sugimura T; Wakabayashi K
Carcinogenesis; 2007 Oct; 28(10):2193-8. PubMed ID: 17510084
[TBL] [Abstract][Full Text] [Related]
43. The melanocortin agonist melanotan II increases insulin sensitivity in OLETF rats.
Banno R; Arima H; Sato I; Hayashi M; Goto M; Sugimura Y; Murase T; Oiso Y
Peptides; 2004 Aug; 25(8):1279-86. PubMed ID: 15350695
[TBL] [Abstract][Full Text] [Related]
44. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
45. Identification of quantitative trait loci for non-insulin-dependent diabetes mellitus that interact with body weight in the Otsuka Long-Evans Tokushima Fatty rat.
Moralejo DH; Wei S; Wei K; Weksler-Zangen S; Koike G; Jacob HJ; Hirashima T; Kawano K; Sugiura K; Sasaki Y; Ogino T; Yamada T; Matsumoto K
Proc Assoc Am Physicians; 1998; 110(6):545-58. PubMed ID: 9824537
[TBL] [Abstract][Full Text] [Related]
46. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
Alemzadeh R; Tushaus K
Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
[TBL] [Abstract][Full Text] [Related]
47. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats.
Chang E; Kim L; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
World J Gastroenterol; 2015 Jul; 21(25):7754-63. PubMed ID: 26167075
[TBL] [Abstract][Full Text] [Related]
48. [Effects of Liuweidihuang pills on plasma adiponectin level in OLETF rats].
Qian Y; Xue YM; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):34-6. PubMed ID: 18227021
[TBL] [Abstract][Full Text] [Related]
49. Fermented mushroom milk-supplemented dietary fibre prevents the onset of obesity and hypertriglyceridaemia in Otsuka Long-Evans Tokushima fatty rats.
Jeon BS; Park JW; Kim BK; Kim HK; Jung TS; Hahm JR; Kim DR; Cho YS; Cha JY
Diabetes Obes Metab; 2005 Nov; 7(6):709-15. PubMed ID: 16219014
[TBL] [Abstract][Full Text] [Related]
50. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
[TBL] [Abstract][Full Text] [Related]
51. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
52. Impact of insulin resistance on the progression of chronic liver diseases.
Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Yoshii J; Yanase K; Namisaki T; Yamazaki M; Moriya K; Tsujimoto T; Kawaratani H; Akahane T; Uemura M; Fukui H
Int J Mol Med; 2008 Dec; 22(6):801-8. PubMed ID: 19020779
[TBL] [Abstract][Full Text] [Related]
53. Genetic evidence for obesity loci involved in the regulation of body fat distribution in obese type 2 diabetes rat, OLETF.
Ogino T; Wei S; Wei K; Moralejo DH; Kose H; Mizuno A; Shima K; Sasaki Y; Yamada T; Matsumoto K
Genomics; 2000 Nov; 70(1):19-25. PubMed ID: 11087657
[TBL] [Abstract][Full Text] [Related]
54. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.
Bergman RN; Kim SP; Hsu IR; Catalano KJ; Chiu JD; Kabir M; Richey JM; Ader M
Am J Med; 2007 Feb; 120(2 Suppl 1):S3-8; discussion S29-32. PubMed ID: 17296343
[TBL] [Abstract][Full Text] [Related]
55. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
56. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
[TBL] [Abstract][Full Text] [Related]
57. Functional lipids and the prevention of the metabolic syndrome.
Yanagita T; Nagao K
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():189-91. PubMed ID: 18296334
[TBL] [Abstract][Full Text] [Related]
58. A mixture of Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces body weight gain, visceral fat accumulation, and total cholesterol and insulin increases in male Wistar fatty rats.
Kishino E; Ito T; Fujita K; Kiuchi Y
Nutr Res; 2009 Jan; 29(1):55-63. PubMed ID: 19185778
[TBL] [Abstract][Full Text] [Related]
59. Reversal of elevated cardiac expression of TGFbeta1 and endothelin-1 in OLETF diabetic rats by long-acting calcium antagonist.
Jesmin S; Zaedi S; Maeda S; Mowa CN; Sakuma I; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):907-12. PubMed ID: 16741022
[TBL] [Abstract][Full Text] [Related]
60. The effects of thiazolidinedione treatment on the regulations of aquaglyceroporins and glycerol kinase in OLETF rats.
Lee DH; Park DB; Lee YK; An CS; Oh YS; Kang JS; Kang SH; Chung MY
Metabolism; 2005 Oct; 54(10):1282-9. PubMed ID: 16154425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
